==============================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report: October 06, 1998 - Commission File No. 0-17746
---------------- -------
SAFE TECHNOLOGIES INTERNATIONAL INCORPORATED
(Formerly Safe Aid Products Incorporated)
----------------------------------------------------
(Exact name of Registrant as specified in its Charter)
Delaware 22-2824492
------------------------------- ---------------------
(State or other jurisdiction of (IRS Employer ID No.)
incorporation or organization)
249 Peruvian Avenue
Suite F2
Palm Beach, Florida 33480
------------------------------- ----------
(Address of principal executive (Zip Code)
offices)
Registrant's telephone number,
including area code: (561) 832-2700
--------------
* On February 9, 1998, Safe Aid Products Incorporated merged with and into
Intelligence Network International and was renamed Safe Technologies
International Incorporated.
============================================================================
Item 5. Other Events
The Company issued a press release today announcing that it had
entered into a License Agreement with Hangzhou Jiuyuan Gene Engineering Co.,
Ltd., located in the state-grade Hangzhou Economic & Technological
Development Zone, P.R. China for the production and distribution of SFAD's
Nasal Aspirin Patent. The information contained in the press release, a
copy of which is attached hereto as Exhibit 99.1 is incorporated herein by
reference.
Signatures
----------
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
SAFE TECHNOLOGIES INTERNATIONAL INCORPORATED
By: /s/ Barbara Tolley
------------------------------
Barbara Tolley, CEO & Chairman
Dated: October 6, 1998